Non-invasive markers of liver fibrosis: How to use them in clinical practice?

Journal of Hepatology

Volumn 46, Issue 3, 2007, Pages 529-530

  Sebastiani, Giada ^a   Alberti, Alfredo ^a  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; MARKER;

ALGORITHM; CHRONIC LIVER DISEASE; CLINICAL PRACTICE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; PRIORITY JOURNAL; VALIDATION STUDY;

EID: 33846616816     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.12.003     Document Type: Letter

References (6)

1. Castera L., Denis J., Babany G., and Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?. J Hepatol 46 (2007) 528-529
2. Almasio P.L., Niero M., Angioli D., Ascione A., Gullini S., Minoli G., et al. Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol 43 (2005) 381-387
3. Sebastiani G., Vario A., Guido M., Noventa F., Plebani M., Pistis R., et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 44 (2006) 686-693
4. Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol, in press.
5. Sebastiani G., and Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 12 (2006) 3682-3694
6. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350